Search
Menu
Home
HTB
2024
November
November 2024
Contents
Special reports
Unheard: The medical practice of silencing – by Dr Rageshri Dhairyawan
Conference reports
Glasgow HIV Congress 2024: Introduction and links
Once-weekly oral ART with islatravir plus lenacapavir sustains results to week 48
EACS guidelines: New format and contents includes chemsex
Double dose start for oral PrEP in new EACS guidelines – rapid protection in two hours
Future PrEP and new results on lenacapavir from PURPOSE 1 and 2 – does HIV exposure explain incident cases?
Liverpool University Drug Interaction website recognised for global impact on research and care
HCV coinfection approaches zero in Spain: but cirrhosis and reinfection among gay men are still significant even with high rates of cure
Dolutegravir/lamivudine vs triple ART have similar efficacy in advanced HIV infection with CD4 <200 and viral load >100,000
Treatment access
Management of drug resistance to integrase inhibitors: results from an international perinatal virtual clinic
mpox
Mpox breakthrough cases after two doses of the MVA-BN vaccine
Coinfections and complications
Bipolar disorder in people living with HIV
On the web
WHO toolkit to strengthen engagement of health workers in emergency responses
HTB RSS
Early access
Vaccination effectively limits mpox progression: lower efficacy in people living with HIV
27 May 2025
US update guidelines for statin use in people living with HIV
26 May 2025
HIV activists in the US call for action and Zachie Achmet brings South African perspective
26 May 2025
Scientific, legal and ethical crisis from halting ongoing NIH studies: TAG statement
22 May 2025
All early access reports
Current issues
May 2025
April 2025
March 2025
Back issues
Special report
Scientific, legal and ethical crisis from halting ongoing NIH studies: TAG statement
22 May 2025
More from HTB
Conference reports
Conference shortcuts
Articles by subject
PDFs
Subscribe
HTB homepage
Home
i-Base homepage
Donate